相关实验视频

Updated: Jul 20, 2026

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

在胆管癌中确定新辅助疗法的指示

Hilary R Keller, Laura Fluke, Jared A Forrester

Oncology (Williston Park, N.Y.)

|April 25, 2024

概括

这项研究检查了胆管癌患者的生存率. 了解这些比率对于改善患者的治疗结果和治疗策略至关重要.

科学领域:

在瘤学瘤学.
胃肠病学胃肠病学

背景情况:

胆管癌 (胆管癌) 存在重大治疗挑战.
准确的生存率数据对于临床决策至关重要.

研究的目的:

分析和呈现当前的存活率为胆管癌.
突出影响胆管癌患者生存的因素.

主要方法:

审查最近的流行病学数据.
对临床试验结果的分析.
对生存概率的统计建模.

主要成果:

介绍中位数和整体存活率.
确定关键的预后指标.
对不同胆管癌亚型的存活率进行比较.

结论:

胆管癌的存活率仍然是研究的关键领域.
对新的治疗方法进行进一步的研究是有必要的.
改善患者分层可以提高治疗疗效.

更多相关视频

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...